GRAY WILLIAM GARRETT

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
13
Insider Sells Sum
$1.47M

Insider Activity of GRAY WILLIAM GARRETT

According to the SEC Form 4 filings, GRAY WILLIAM GARRETT, being in a position of

  1. Chief Financial Officer at Checkpoint Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 287620 shares for $1.12M,
    over all time since 2020-05-21, has bought 0 shares, and sold 419227 shares for $1.47M.

The largest sale of all time was on 2024-12-18 and amounted to 268432 shares of Checkpoint Therapeutics, Inc. for $1.08M.

Biography of GRAY WILLIAM GARRETT

No biography is available at this moment.

2024-12-18SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
268,432
0.6445%
$4.01$1.08M0%
2024-06-26SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
13,038
0.0359%
$2.06$26,858+22.22%
2024-02-28SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
2,035
0.0086%
$2.07$4,212+7.07%
2024-02-01SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
4,115
0.0185%
$1.95$8,024+8.67%
2023-03-02SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
3,591
<0.0001%
$5.00$17,955-55.93%
2023-02-27SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
1,914
<0.0001%
$4.66$8,919-51.41%
2023-02-01SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
3,154
<0.0001%
$4.79$15,108-50.47%
2023-01-10SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
1,858
<0.0001%
$6.75$12,540-62.55%
2022-03-10SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
38,197
0.0447%
$1.89$72,307-43.68%
2022-02-01SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
37,063
0.0429%
$2.51$92,954-55.69%
2021-02-04SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
26,320
0.0387%
$3.66$96,318-16.1%
2020-12-22SaleCheckpoint Therapeutics, Inc.
CKPT
Chief Financial Officer
2,406
0.0044%
$2.79$6,713+13.43%
2020-05-21SaleCheckpoint Therapeutics, Inc.
CKPT
See Remarks
17,104
0.032%
$2.00$34,122+25.73%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.